# Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/par-21-120-global-infectious-disease-research-training-program-d43/  
Official notice: https://www.grants.gov/search-results-detail/331590

> National Institutes of Health offered grants to colleges and universities. Applications closed on August 3, 2023.

| Field | Value |
|---|---|
| Opportunity number | PAR-21-120 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | August 3, 2023 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.855, 93.989 |

## Who can apply

- Public and State controlled institutions of higher education
- Private institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) ; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

## What the grant funds

This Funding Opportunity Announcement (FOA) encourages joint applications for the Global Infectious Disease (GID) Research Training programs from U.S. and low- and middle-income country (LMIC) institutions. The application should propose a collaborative training program that will strengthen the capacity of a LMIC institution to conduct infectious disease research. FIC will support research-training programs that focus on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, infections that frequently occur as co-infections in HIV infected individuals or infections associated with non-communicable disease conditions of public health importance in LMICs. Training related to prevention, treatment or public health approaches to any technical area of basic, epidemiology, clinical, behavioral or social science health research may be supported. Research Training programs should incorporate didactic, mentored research and career development skills components to prepare individuals for careers that will have significant impact on the priority health research needs of LMICs. This Funding Opportunity Announcement (FOA) allows support of [trainees] as the lead investigator of an independent clinical trial; or a separate ancillary clinical trial or proposing to gain research experience in a clinical trial led by another investigator, as part of their research and career development.

## Questions people ask

### Is PAR-21-120 still open?

No. It closed on August 3, 2023.

### Who can apply for Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)?

National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)?

Closed August 3, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### Who has been funded under PAR-21-120?

NIH RePORTER lists 22 projects funded under PAR-21-120 in fiscal 2022 to 2026, at 19 institutions. The most were at Emory University, University of Virginia, Univ of Sciences, Tech & Tech of Bamako.

### Who has won Allergy and Infectious Diseases Research grants before?

The largest recipients over five fiscal years were Fred Hutchinson Cancer Center, Duke University, University of California, Los Angeles. The program made 13,282 awards worth $22 billion in that time.